South Wales, Sept. 18 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "AREXERA THERAPEUTICS" on Sept. 2. The details about the trademark application no. UK00004439670 published in the journal no. 2026/038 (Sept. 18).
With HGF Limited as representative, Atalanta Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurodegenerative diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of human diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurological diseases and disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of pain; Pharmaceutical preparations, namely, RNA therapeutics for the treatment diseases of the central nervous system.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004439670
Disclaimer: Curated by HT Syndication.
